Moreover, the serum protein biomarker CCL11 (eotaxin-1), a potent chemotactic agent for basophils, is elevated in individuals with prostate cancer (30), highlighting its role in regulating immune responses and advancing tumor progression. The gene discussed is CCL11; the disease is prostate cancer.